n a genetically engineered anti-TNF compound (trade name Enbrel) consisting of receptors that bind TNF; it is injected twice a week in the treatment of rheumatoid arthritis
Amgen Drug Faces Challenge Enbrel, a blockbuster drug made by Amgen Inc. is no more effective than a cocktail of cheaper generic therapies in treating rheumatoid arthritis, according to a new study funded by the Department of Veterans Affairs, the Wall Street Journal reports.
June 12, 2013 - Los Angeles Business Journal